You are here: Home » News-CM » Companies » News
Business Standard

Dr. Reddy's Laboratories launches Chlorthalidone Tablets in US market

Capital Market 

announced the launch of Chlorthalidone Tablets USP, 25 mg and 50 mg, a therapeutic equivalent generic version of Hygroton (chlorthalidone) Tablets, approved by the

(USFDA).

The Hygroton brand and generic had U. S. sales of approximately $122 million MAT for the most recent twelve months ending in September 2018 according to IMS

Dr. Reddy's Chlorthalidone Tablets, USP are available in 25 mg tablets in the bottle-count sizes of 100 and 1000, and 50 mg tablets in the bottle-count size of 100.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, November 28 2018. 11:12 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU